NOM invests in PulmoTech

We are excited to announce that NV NOM invests in PulmoTech BV!

With this new investment, and the continued support of Carduso Capital B.V, we will be able to bring workflow friendly esophageal pressure measurements to clinical practise with a CE-marked device. Jointly with Leo Heunks and Annemijn Jonkman, PhD, this investment also allows for our next clinical investigation at Erasmus MC, so stay tuned.

Bringing an innovative device to market within the current European regulatory framework takes a long breath, but we remain determined to make this promising technology available to patients who need it the most.

See link to the press release here (in Dutch):

A big thanks to all the support along the way!